Σύνδεση
Childen receive vaccine against malaria, in Douala, Cameroon - 22 Jan 2024
Childen receive vaccine against malaria, in Douala, Cameroon - 22 Jan 2024
Childen receive vaccine against malaria, in Douala, Cameroon - 22 Jan 2024
Childen receive vaccine against malaria, in Douala, Cameroon - 22 Jan 2024
Childen receive vaccine against malaria, in Douala, Cameroon - 22 Jan 2024
Childen receive vaccine against malaria, in Douala, Cameroon - 22 Jan 2024
Childen receive vaccine against malaria, in Douala, Cameroon - 22 Jan 2024
14312095g
Περιγραφή για Εικόνα

Κωδικός για Εικόνα στοκ: 14312095g

Childen receive vaccine against malaria, in Douala, Cameroon - 22 Jan 2024

A nurse prepares to vaccinate a child against malaria in Nyalla Medical Centre in Douala, Cameroon, 22 January 2024. A new malaria vaccine, known as RTS,S, or Mosquirix, made by GlaxoSmithKline, is being rolled out for the first time as an immunization campaign for children in Cameroon. According to the World Health Organisation, the WHO African Region, with an estimated 233 million cases in 2022, accounted for about 94% of cases globally. Malaria is highly endemic in Cameroon and the WHO estimates that about 11,000 people die from malaria in Cameroon every year.

Σημαντικές πληροφορίες

Μορφές για Εικόνα

Συνεργάτης για Εικόνα

DONGMO RODRIGUE WILLIAM/EPA-EFE/Shutterstock

Συναφείς λέξεις-κλειδιά

© 2003-2024 Shutterstock, Inc.